Uruguay currently authorizes the legal sales of four different cannabis strains through the nation’s licensed pharmacies. As of the start of this month, the prices that the government sets for the different strain options have gone up by a marginal amount.

“With the new values, the Alpha variety went from $480 to $485; Beta from $500 to $505; Gamma from $560 to $565; and Epsilon from $610 to $615.” reported San Jose Ahora in its local coverage (translated from Spanish to English).

“The IRCCA system automatically verifies that the limits established by current regulations are not exceeded: up to 10 grams in the last seven days, 40 grams in the last 30 days, and 480 grams in a 12-month period.” the outlet also reported.

This is not the first time that the government has raised prices for legal cannabis flower sold through Uruguayan pharmacies. Back in August 2025, the Institute for the Regulation and Control of Cannabis (IRCCA) raised prices on the four approved strains by $10.

Lawmakers in Uruguay adopted a national adult-use cannabis legalization measure in 2013, making it the first country in the world to do so. Legal cannabis sales through the nation’s registered pharmacies began in 2017.

Adult residents in Uruguay can register to source cannabis legally in one of three ways. The first is through pharmacies, and the other two are home cultivation and cultivation associations. Originally, only two strains were approved to be sold through pharmacies, but that has since expanded to four strains.

The first two strains sold in pharmacies were ‘Alpha’ and ‘Beta’, each with tetrahydrocannabinol (THC) levels equal to or less than 9%, and cannabidiol (CBD) levels equal to or less than 3%. Then, in 2022, Uruguay permitted a third option, ‘Gamma,’ which has a THC level of equal to or less than 15%, and CBD levels of equal to or less than 1%. The ‘Epsilon’ strain, which has a THC content of equal to or less than 20% and a CBD content of equal to or less than 1%, was approved in late 2024.

Sales statistics from IRCCA for the 2025 calendar year were recently analyzed, and the industry data for the nation’s legal adult-use cannabis market demonstrates strong growth.

“One ton more cannabis was sold in licensed pharmacies in 2025 compared to recent years, according to data from the Institute for the Regulation and Control of Cannabis ( IRCCA ) accessed by El País. Purchases of the drug by registered users in pharmacies reached 4,290 kilos last year, exceeding the figures for 2024 (3,207) and 2023 (3,254).” El País reported in its local coverage (translated from Spanish to English).

“The production of four cannabis varieties ( alpha , beta , gamma , and epsilon ) available in some pharmacies across the country, cultivated by state-authorized companies on guarded land in Libertad (San José), reached 4,658 kilos last year, also exceeding the amounts cultivated in 2024 (3,374) and 2023 (2,767). This is the largest volume of the drug produced and sold in pharmacies to date, since production began in 2017. Prior to 2022, this figure hovered around 2,000 kilos.” the outlet also reported.